Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The new generation of Alzheimer’s drugs — the first proven to change the course of the disease — work by tagging amyloid for […]
Two studies of commercially available biomarkers of synucleinopathies have reached sharply different conclusions on their reliability, according to the findings from two abstracts presented at the AAN Annual Meeting, held in Denver in April.
Erik S. Musiek, MD, PhD, a professor of Neurology at Washington University School of Medicine in St. Louis, was installed as the Charlotte and Paul Hagemann Professor of Neurology at a ceremony on Thursday, March 28, 2024 at the Eric P. Newman Education Center. At the ceremony, Musiek presented the talk titled, “Circadian clocks and […]
Robin Ryther, MD, PhD, was born and raised in St. Louis, MO. For the locals, she attended Parkway Central High School. Ryther received a BS in biochemistry from the University of Missouri at Columbia before heading to Vanderbilt University for her MD and PhD (molecular biology). She then moved to Boston for her pediatric and […]
Rebecca “Becky” Liddick came from Washington state to Missouri in 2007. And two weeks later, she became a member of the Washington University in St. Louis family. She is now a new patient coordinator for the Department of Neurology. Prior to moving to St. Louis, Liddick was a foster parent and a caregiver for the […]
Alzheimer’s disease (AD) is a neurodegenerative disorder that results in progressive loss of cognitive function. It is critical to identify individuals who are at the highest risk of developing AD as early as possible so that appropriate treatment plans can be developed. Neuropsychological tests of psychomotor speed, attention, and memory are frequently used to assess […]
In honor of World Down syndrome Day on March 21, we are exploring the link between Down syndrome and Alzheimer’s disease. We partnered with our 4YOU charity, the Down Syndrome Association of Greater St. Louis, to learn more. Click here to learn more about the Down Syndrome Association of Greater St. Louis.
Washington University Institute of Clinical and Translational Sciences (ICTS) and The Foundation for Barnes-Jewish Hospital have awarded Stefanie Geisler, MD, and Laura McPherson, PT, DPT, PhD, grants as part of the 17th annual Clinical and Translational Research Funding Program (CTRFP). This program is the largest internal grant funding program in the ICTS, requiring applicants to […]
Congratulations and welcome to our 2024-2025 residency intern class! We are so excited to welcome this diverse and fantastic group of trainees who are among the best of the best. The Adult Neurology cohort will begin its PGY1 Preliminary Medicine year in July 2024 and its PGY2 Neurology training in July 2025. The Pediatric Neurology […]
In the realm of biomedical research, securing funding is a testament to an institution’s record of scientific accomplishments and potential for further advances to improve human health. In 2023, Washington University School of Medicine in St. Louis received the second-highest amount of funding from the National Institutes of Health (NIH) of all medical schools nationwide. […]